| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |